Abstract
ObjectiveTo characterize potential drug safety signals identified from the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS), from 2008 to 2019, to determine how often these signals...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have